COMMUNIQUÉS West-GlobeNewswire

Maple Leaf Green World Inc. Engages Emerging Equity Inc. to Raise $20 Million Private Placement

03/05/2018 - 14:30

CALGARY, Alberta, May 03, 2018 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“ Maple Leaf ” or the “ Company ”) (NEO: MGW ) (OTCQB:MGWFF) is pleased to announce that it has entered into an engagement letter with [...]

Delcath Announces Another DSMB Recommendation for Phase 3 Focus Trial

03/05/2018 - 14:30

FOCUS trial to continue without modification NEW YORK, May 03, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology company focused on the treatment of primary and metastatic liver [...]

DiaMedica Announces Positive Results From FDA Meeting on Planned Clinical Trial in Patients with Chronic Kidney Disease

03/05/2018 - 14:30

DiaMedica has received final minutes from Type B meeting with the US FDA DiaMedica preparing to submit an IND to initiate DM199 clinical study in patients with chronic kidney disease in the US MINNEAPOLIS, May 03, 2018 [...]

Israeli Cancer Research Firm Vaxil Granted 9th Patent for Immunotherapy Treatment

03/05/2018 - 14:30

Provides Corporate Update ISRAEL and TORONTO, May 03, 2018 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (TSX VENTURE:VXL), a cancer research biotechnology company focused on innovative immunotherapy treatments, has been granted a [...]

Surgery Partners, Inc. Announces First Quarter 2018 Earnings Release Date and Conference Call Details

03/05/2018 - 14:30

NASHVILLE, Tenn., May 03, 2018 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ: SGRY ) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced that the Company will release its [...]

Moleculin Announces Engagement with Voisin Consulting Life Sciences to Expand Annamycin Clinical Trial

03/05/2018 - 14:30

HOUSTON, May 03, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX ) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of [...]

Scythian Announces Marigold’s Exclusive Agreement with Jamaica’s Peter Tosh Museum

03/05/2018 - 14:30

— Medicinal Cannabis Dispensary to open in Peter Tosh Square — — Peter Tosh Square to be the home of Marigold ’s first herb house — TORONTO, May 03, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company " [...]

Viveve to Announce First Quarter 2018 Financial Results

03/05/2018 - 14:28

Conference Call and Webcast Scheduled for Thursday, May 10, 2018 ENGLEWOOD, Colo., May 03, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE ), a medical technology company focused on women's intimate health, [...]

William Demant Holding A/S: Completion of capital reduction

03/05/2018 - 14:24

Company announcement no 2018-05 3 May 2018 Completion of capital reduction in William Demant Holding A/S As stated in Company announcement no. 2018-04, it was decided at William Demant Holding A/S’ ordinary general [...]

Organovo and Samsara Sciences Partner with New Manufacturing USA Institute

03/05/2018 - 14:05

The Advanced Regenerative Manufacturing Institute (ARMI) will receive nearly $300 million in public-private investment from leading manufacturers, universities, nonprofit organizations and the federal government to [...]

Shire plc : Director/PDMR Shareholding

03/05/2018 - 14:01

Director/PDMR Shareholding May 3, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") Notification of transactions by person discharging managerial responsibilities 1. Details of the person discharging managerial [...]

Iovance Biotherapeutics to Host First Quarter 2018 Financial Results Conference Call and Webcast on Thursday, May 10, 2018

03/05/2018 - 14:01

SAN CARLOS, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA ), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology [...]

Evolus to Present at the Bank of America Merrill Lynch 2018 Health Care Conference

03/05/2018 - 14:01

IRVINE, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS ) (“Evolus”), a lifestyle aesthetics company focused on delivering advanced aesthetic procedures and treatments to physicians and consumers, [...]

Five million doses of Prevtec Microbia’s bivalent vaccine Coliprotec® F4/F18 Sold in the European Union

03/05/2018 - 14:00

MONTREAL, May 03, 2018 (GLOBE NEWSWIRE) -- Prevtec Microbia Inc. (“Prevtec”) is pleased to announce that five million doses of its bivalent vaccine Coliprotec® F4/F18 have been sold in the European Union (EU) since its [...]

Prevtec Microbia atteint le seuil de cinq millions de doses vendues en Union Européenne pour son vaccin bivalent Coliprotec® F4/F18

03/05/2018 - 14:00

MONTRÉAL, 03 mai 2018 (GLOBE NEWSWIRE) -- Prevtec Microbia Inc. (« Prevtec ») a le plaisir d’annoncer que son vaccin bivalent Coliprotec® F4/F18 a atteint le seuil de cinq millions de doses vendues en Union Européenne ( [...]

Onconova Therapeutics to Present at the Disruptive Growth and Healthcare Conference on May 8th, 2018

03/05/2018 - 14:00

NEWTOWN, Pa., May 03, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX ), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary [...]

Pieris Pharmaceuticals to Present at 43rd Annual Deutsche Bank Health Care Conference

03/05/2018 - 14:00

BOSTON, May 03, 2018 (GLOBE NEWSWIRE) -- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS ) , a biotechnology company advancing novel biotherapeutics through its proprietary Anticalin ® technology platform for cancer, [...]

CASMED to Report First-Quarter 2018 Financial Results and Hold Conference Call on May 10

03/05/2018 - 14:00

BRANFORD, Conn., May 03, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM ) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces that it will report financial results for [...]

Athenex, Inc. to Report First Quarter Earnings Results on May 14, 2018

03/05/2018 - 14:00

BUFFALO, N.Y., May 03, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]